Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Pivanex, a Histone Deacetylase Inhibitor, in Patients With Malignant Melanoma

NCT00087477 is registered in ClinicalTrials.gov with Titan Pharmaceuticals as lead sponsor.

NCT NCT00087477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00087477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Pivanex, a Histone Deacetylase Inhibitor, in Patients With Malignant Melanoma
Lead sponsor
Titan Pharmaceuticals
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2004
Completion date
August 31, 2004
Enrollment
14
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma